Australia markets open in 9 hours 13 minutes

Claritas Pharmaceuticals, Inc. (KALTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1222-0.0777 (-38.87%)
At close: 03:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.1999
Open0.1219
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.1185 - 0.1222
52-week range0.0020 - 2.0000
Volume61,923
Avg. volume18,990
Market cap4.339M
Beta (5Y monthly)2.68
PE ratio (TTM)N/A
EPS (TTM)-0.1520
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Claritas Provides Update Regarding Phase 1 Clinical Study

    SAN FRANCISCO and TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today provided an update regarding the expected time to completion of its Phase 1 clinical study of R-107, the Company’s proprietary, liquid, nitric oxide-releasing compound (the “Phase 1 Study”). Phase 1 Study to be Completed at Scientia Clinical Research Claritas is focused on completing the Phase 1 Study as quickly as possible. Due to the

  • GlobeNewswire

    Claritas Announces Engagement of B. Riley Securities as Sponsor for the Company’s Planned Up-Listing of its Securities to the OTCQB

    SAN FRANCISCO and TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: CLAS.V) (the "Company" or "Claritas") today announced the engagement of B. Riley Securities, Inc. (“B. Riley Securities”) as its exclusive capital markets advisor with respect to the Company’s planned up-listing of its securities on the OTCQB. "We view the planned up-listing on the OTCQB as an important milestone for Claritas," stated Robert Farrell, Claritas’ President and CEO

  • GlobeNewswire

    Claritas Announces Closing of Convertible Debenture Financing with Obsidian Global GP, LLC

    SAN FRANCISCO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: CLAS.V) (the "Company" or "Claritas") is pleased to announce that it has closed the first tranche of a private placement offering (the “Offering”) of convertible debentures with Obsidian Global GP, LLC (“Obsidian”) for net proceeds of USD $930,000. Highlights Claritas received aggregate proceeds of approximately CAD $1,247,000 (the “Aggregate Proceeds”) from the closing. Subject to the sat